Latest Hematology Cancer Research to Be Unveiled at 2026 ASH Annual Meeting & Exposition
At the 68th ASH Meeting & Exposition, Dec. 12-15, 2026, in New Orleans, City of Hope® experts will share the latest research and clinical innovations shaping care for patients with blood cancers and related disorders, including new therapies and ongoing clinical trials.
Visit us at booth No. 3423 to connect with City of Hope leaders who are redefining cancer care through innovations in bone marrow and stem cell transplants, CAR T cell therapies and microbiome research. Learn more about our Hematopoietic Cell Transplantation and Cellular Therapy Fellowship Programs and how we’re shaping the next generation of specialists in hematologic care.
Home to one of the nation’s largest and most successful bone marrow transplant and cellular therapy programs, City of Hope continues to translate discoveries into improved outcomes for patients.
R.S.V.P. Now for an Evening with City of Hope
Saturday, Dec. 12, 2026
7:30 to 9 p.m. CST
Vue Orleans
2 Canal Street
New Orleans, Louisiana 70130
Hosted by
Marcel van den Brink is president of City of Hope Los Angeles and National Medical Center and serves as chief physician executive. A globally recognized leader in bone marrow transplantation and microbiome and cancer immunotherapy, he is widely respected for his collaborative leadership as well as
15th Annual Bone Marrow Transplant and Cell Therapy Winter Workshop
Dec. 11, 2026, 1:30 pm CST
Audubon Aquarium
1 Canal Street
New Orleans, Louisiana 70130
The workshop will continue to build on progressive and innovative research with 18 rapid fire talks by various experts covering unpublished clinical and pre-clinical data pertinent to hematopoietic stem cell transplantation and cell therapy.
Attendees can look forward to exceptional speakers and opportunities to connect with one and another in breakout sessions to discuss talks. Now all we need is you.
Meet and greet, 1:30 p.m.-2:30 p.m. CST
Workshop, 2:30 p.m.-6:30 p.m. CST
Reception and networking, 6:30 p.m.-8 p.m. CST
Co-Chair
Marcel van den Brink is president of City of Hope Los Angeles and National Medical Center and serves as chief physician executive. A globally recognized leader in bone marrow transplantation and microbiome and cancer immunotherapy, he is widely respected for his collaborative leadership as well as
Co-Chair
Edmund K. Waller, M.D., Ph.D.
Director, Regenerative Engineering and Medicine (REM) Center, Emory University, DeKalb County, Georgia
Co-Host
Benjamin K. Watkins, M.D.
Marcelle Schaefer Vergara Chair in Pediatric Hematology/Oncology; Division Chief, Pediatric Hematology and Oncology, Tulane University School of Medicine, New Orleans, Louisiana
Director of the Stem Cell Transplant and Cellular Therapy Program, Manning Family Children's, New Orleans, Louisiana
Resources
City of Hope is the largest and most successful bone marrow and blood stem cell transplant program in the nation, with over 20,000 bone marrow transplant procedures performed to date — both autologous and allogeneic — through our cancer centers in Duarte, California, Phoenix, Chicago and Atlanta.
Our dedicated, multidisciplinary team of health care and research professionals combine innovative research discoveries with superior clinical treatments to improve outcomes for patients with hematologic cancers.
As a pioneer in advancing care for all hematologic cancers and related blood disorders, City of Hope's Department of Hematology & Hematopoietic Cell Transplantation leads the field as one of the largest and most successful transplant centers in the U.S.
One of the most promising areas of cancer research and treatment is known as immunotherapy, in which a patient’s own immune system is enlisted in the fight against cancer. This approach is more than just a narrow field of study at City of Hope. It is the central component of groundbreaking research and clinical trials currently underway.
In the global pursuit of scientific miracles in the fight against deadly diseases, the Beckman Research Institute of City of Hope is among those leading the charge. Its world-renowned staff have been responsible for fundamentally expanding the world’s understanding of how biology affects diseases such as cancer, HIV/AIDS and diabetes.
We’re aggressively pursuing ways to help our patients right now — not years from now. That immediacy of focus makes City of Hope a worldwide leader in administering clinical trials. Each year, we conduct more than 730 clinical trials enrolling more than 5,000 patients.
We are a leader in clinical and translational research, most notably in antibody-based therapy, CAR T cell therapy and bone marrow transplant approaches. When you refer your patient to City of Hope, you can do so with the utmost confidence that our staff will provide the best care possible for your patient.
We’re looking for extraordinary individuals to join our internationally renowned community of physicians, researchers and other health care professionals.
Hosted by Sumanta (Monty) Pal, M.D., F.A.S.C.O., co-director of the Kidney Cancer Program on the Duarte campus, the podcast, "On the Edge of Breakthrough: Voices of Cancer Research" features world-leading oncology experts who explore the latest scientific research and clinical innovations shaping the future of cancer treatment and care.
